Vivatech International, Inc.
Clinical trials sponsored by Vivatech International, Inc., explained in plain language.
-
Could your own cells ease hip arthritis pain? new study investigates
Symptom relief Recruiting nowThis study tests whether using a patient's own regenerative cells can safely reduce pain and inflammation from hip osteoarthritis. Researchers will first treat 50 people, then expand to 4,000 participants. They will measure changes in pain, quality of life, and look for cartilage…
Phase: PHASE2 • Sponsor: VivaTech International, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Could your own cells ease knee arthritis pain? new study investigates
Symptom relief Recruiting nowThis study is testing whether using a patient's own cells can safely reduce pain and inflammation from knee osteoarthritis. It will involve 4,000 participants with moderate to severe knee arthritis. Researchers will track pain, knee function, and look for cartilage regrowth using…
Phase: PHASE2 • Sponsor: VivaTech International, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC
-
Could your own cells fix your shoulder arthritis?
Symptom relief Recruiting nowThis study tests if using a patient's own cells can safely reduce pain and swelling from shoulder arthritis. First, 50 people will try the treatment, then up to 4,000 more will join. The goal is to see if the therapy helps with daily activities and might even regrow cartilage.
Phase: PHASE2 • Sponsor: VivaTech International, Inc. • Aim: Symptom relief
Last updated May 07, 2026 18:43 UTC